Jubilant Life Sciences’ arm gets EIR from USFDA for Solid Dosage facility at Salisbury

01 Apr 2020 Evaluate

Jubilant Life Sciences’ material wholly owned subsidiary -- Jubilant Pharma, through one of its wholly owned subsidiaries, has received the Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the USFDA for its Solid Dosage Facility at Salisbury, Maryland USA in respect of the inspection conducted by the regulatory agency from February 24, 2020 to February 28, 2020. With the receipt of the EIR, the inspection stands successfully closed. 

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.

Jubilant Pharmova Share Price

1059.00 3.10 (0.29%)
02-Jan-2026 09:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.00
Dr. Reddys Lab 1236.55
Cipla 1499.85
Zydus Lifesciences 912.40
Lupin 2100.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×